Kezar Life Sciences Inc (KZR)
0.7633
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.7633
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Cash from Financing (Quarterly): 0.00 for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.059M |
September 30, 2023 | 0.043M |
June 30, 2023 | 0.382M |
March 31, 2023 | 0.154M |
December 31, 2022 | 0.506M |
September 30, 2022 | 0.185M |
June 30, 2022 | 78.32M |
March 31, 2022 | 48.85M |
December 31, 2021 | 99.36M |
September 30, 2021 | 2.212M |
June 30, 2021 | 0.282M |
March 31, 2021 | 10.74M |
December 31, 2020 | 0.317M |
September 30, 2020 | 1.962M |
Date | Value |
---|---|
June 30, 2020 | 44.00M |
March 31, 2020 | 53.37M |
December 31, 2019 | 0.08M |
September 30, 2019 | 0.008M |
June 30, 2019 | 0.18M |
March 31, 2019 | 0.004M |
December 31, 2018 | 0.005M |
September 30, 2018 | -1.087M |
June 30, 2018 | 78.97M |
March 31, 2018 | 0.025M |
December 31, 2017 | 0.00 |
September 30, 2017 | 7.341M |
June 30, 2017 | 42.41M |
March 31, 2017 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2024
99.36M
Maximum
Dec 2021
17.05M
Average
0.3495M
Median
Cash from Financing (Quarterly) Benchmarks
Accuray Inc | -1.50M |
Tonix Pharmaceuticals Holding Corp | 40.71M |
Acumen Pharmaceuticals Inc | 7.107M |
NovaBay Pharmaceuticals Inc | -0.597M |
Palatin Technologies Inc | 4.974M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -22.86M |
Cash from Investing (Quarterly) | 20.41M |
Free Cash Flow | -83.65M |
Free Cash Flow Per Share (Quarterly) | -0.314 |
Free Cash Flow Yield | -150.8% |